Bill Information for s1414-119

Long Title

A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.

Short Title

Expedited Access to Biosimilars Act

Vote Information

Status: REFERRED as of 2025-04-10 00:00:00.

Sponsor: This bill was sponsored by Rand Paul (R-KY).

Party line votes are determined based on this being a R-sponsored piece of legislation. See here for information on how party line votes are determined.

Vote count: There were 0 roll call votes on this bill in total.